Cabaletta Bio, Inc. (CABA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 223.96M |
| Enterprise Value | 168.07M |
| P/E Ratio | -1.59 |
| PEG Ratio | -0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 3.39 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -2.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.18 |
| Return On Equity | -1.32 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -164.21M |
| Net Income | -167.86M |
| Diluted EPS | -1.64 |
Balance Sheet
| Total Cash | 116.64M |
| Total Cash/Share | 1.04 |
| Total Debt | 26.45M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 2.95 |
| Book Value Per Share | 0.92 |
Price History
| 52-Week Change | 83.04 |
| 52-Week High | 4.23 |
| 52-Week Low | 1.26 |
| Moving Average 50 Days | 3.32 |
| Moving Average 200 Days | 2.83 |
Statistics
| Average Volume | 4.72M |
| Shares Outstanding | 163.05M |
| % Held by Institutions | 82.8 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
